Dana-Farber Cancer Institute
P

Multiple Myeloma 101: Diagnosis, Prognosis, and Risk

By Dana-Farber Cancer Institute FEATURING Paul Richardson
By Dana-Farber Cancer Institute FEATURING Paul Richardson
0 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
25:23
Houston Methodist Hospital

Whole-Body MRI: Past, Present, and Future

Feat. N. Gupta
35:27
Dana-Farber Cancer Institute

Advances in Multiple Myeloma 2024: From Bench to Bedside

Feat. K. Anderson
23:34
MyCancerHaven

Experts Discuss the Diagnosis and Management of High-Risk Multiple M…

Feat. R. Vij, M. Alsina
22:02
Rush University Medical Center

High-Risk Myeloma: Updates in Defining and Managing

Feat. J. Zonder
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
19:56
Yale Cancer Center

Frontline Treatment Strategies in MM: A Comprehensive Overview of Cl…

Feat. T. Parker
25:52
Rush University Medical Center

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Feat. A. Suvannasankha
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
26:24
Dana-Farber Cancer Institute

Myeloma 101: Diagnosis, Prognosis & Risk

Feat. N. Munshi
15:21
MyCancerHaven

Response Assessment and Utility of MRD in Multiple Myeloma

Feat. R. Vij, A. Rossi
42:37
University of Colorado Department of Medicine

Multiple Myeloma in 2023: An Oncological Success Story

Feat. P. Forsberg
10:13
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: MM

Feat. K. Patel
47:04
Dana-Farber Cancer Institute

Future Directions for Novel & Next Gen Therapy in the Management…

Feat. P. Richardson
45:43
MedNews Week

Multiple Myeloma in 2022: Developments, Directions, and Disparities

Feat. J. Mikhael
20:28
Dana-Farber Cancer Institute

The PROMISE of Early Detection and Interception in Myeloma

Feat. I. Ghobrial
19:18
Total Health

Updates to Management of Patients With Multiple Myeloma

Feat. S. Kumar
22:33
5th SOHO Italy Annual Conference

SOHO Italy 2023: How & When to Integrate Flow Cytometry in the D…

Feat. B. Paiva
26:10
MyCancerHaven

Multiple Myeloma 101: Epidemiology, Diagnosis and Staging

Feat. R. Vij, S. Kumar
11:18
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Manage Bone Disease and its Complications in …

Feat. E. Terpos
43:50
MyCancerHaven

The Basics of Diagnostic Testing in Multiple Myeloma: How to Interpr…

Feat. R. Vij, C. Emmitt Cole